PepGen
PepGen is a seed startup based in United States. 1 investor tracked.
About PepGen
Based in the United States, PepGen is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
PepGen is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases. The company utilizes its Enhanced Delivery Oligonucleotide (EDO) platform to deliver therapeutic oligonucleotides to target tissues, particularly muscle and the central nervous system.
Explore PepGen's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.